Hydromer, Inc. (OTC: HYDI), a long-established innovator in specialty medical coatings and surface technologies, announced a new commercial partnership with Avem Market Solutions to strengthen its reach and technical support capabilities for medical device developers throughout Europe and the United Kingdom.
For decades, Hydromer’s coatings have been integrated into devices used in interventional, surgical, and diagnostic procedures worldwide. By partnering with Avem, an organization renowned for connecting Medtech OEMs and CDMOs with specialized suppliers, Hydromer is creating a more accessible path for European device manufacturers who require advanced surface solutions.
As Hydromer’s strategic representative in the region, Avem will provide direct access to hydrophilic, lubricious, antimicrobial, and thrombo-resistant coating platforms, custom formulation and R&D support for early development, scalable coating equipment and tailored system design, and localized commercial guidance from a team immersed in the EU and UK medtech ecosystems. The goal is to help developers reduce time to market, enhance device performance, and streamline the transition from prototype to full-scale manufacturing.
European and UK medtech companies face increasing pressure to innovate quickly while meeting strict regulatory expectations. This partnership brings together deep scientific expertise and regional commercial insight to make advanced coating solutions easier to access, understand, and implement. By combining Hydromer’s technical capabilities with Avem’s vast network and on-the-ground presence, device manufacturers gain earlier visibility into validated coating options, hands-on support for feasibility studies and scale-up, a reliable resource for navigating technical and operational challenges, and a direct channel to explore coating technologies proven in global markets.
Hydromer, Inc. is an ISO 9001:2015 global B2B surface modification and coating solutions provider offering polymer R&D and manufacturing services for a wide variety of applications. The company is domiciled in Concord, NC, and its customers are located across the United States, Europe, and Asia-Pacific. Its facilities are compliant with Good Manufacturing Practice (GMP), ISO 13485, and ISO 9001. For over four decades, Hydromer has developed value-added solutions to serve businesses in domestic and international markets in a wide range of industries. The company manages numerous global B2B services such as the sale of proprietary coating formulations, custom coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support.
Avem, based in Galway, Ireland, specializes in strategic market development, contract technical sales, and commercial operations solutions exclusively for the B2B medical technology sector. The organization is deliberately structured to help innovative contract design and manufacturing suppliers at varying stages of the supply chain to enter and scale their commercial and business development presence in Europe. More information is available at NewMediaWire.
